139 related articles for article (PubMed ID: 37804815)
1. Gene Expression Changes in the Ovary Mediate Non-Anovulatory Mechanisms of Contraception with Levonorgestrel.
Hernández-Silva G; Vega CC; Barrera D; Hernández-Pando R; García-Uribe PÁ; Chirinos M; Larrea F
Arch Med Res; 2023 Nov; 54(7):102892. PubMed ID: 37804815
[TBL] [Abstract][Full Text] [Related]
2. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
3. Effects of levonorgestrel on ovarian function when used for emergency contraception.
Gemzell-Danielsson K
Minerva Ginecol; 2006 Jun; 58(3):205-7. PubMed ID: 16783291
[TBL] [Abstract][Full Text] [Related]
4. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation.
Noé G; Croxatto HB; Salvatierra AM; Reyes V; Villarroel C; Muñoz C; Morales G; Retamales A
Contraception; 2011 Nov; 84(5):486-92. PubMed ID: 22018122
[TBL] [Abstract][Full Text] [Related]
5. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1989 Feb; 39(2):195-204. PubMed ID: 2495893
[TBL] [Abstract][Full Text] [Related]
6. Post-coital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella.
Ortiz ME; Ortiz RE; Fuentes MA; Parraguez VH; Croxatto HB
Hum Reprod; 2004 Jun; 19(6):1352-6. PubMed ID: 15105392
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
8. Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.
Nave R; Höchel J; Mellinger U; Kohnke A; Elliesen J; Schmitz H
Hum Reprod; 2020 Nov; 35(11):2515-2523. PubMed ID: 32914172
[TBL] [Abstract][Full Text] [Related]
9. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
Brache V; Cochon L; Deniaud M; Croxatto HB
Contraception; 2013 Nov; 88(5):611-8. PubMed ID: 23809278
[TBL] [Abstract][Full Text] [Related]
10. [Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse].
Jamin C
Gynecol Obstet Fertil; 2015 Mar; 43(3):242-7. PubMed ID: 25703406
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of oral emergency contraception.
Gemzell-Danielsson K; Berger C; Lalitkumar PG
Gynecol Endocrinol; 2014 Oct; 30(10):685-7. PubMed ID: 25117156
[TBL] [Abstract][Full Text] [Related]
12. UPA and LNG in emergency contraception: the information by EMA and the scientific evidences indicate a prevalent anti-implantation effect.
Mozzanega B; Nardelli GB
Eur J Contracept Reprod Health Care; 2019 Feb; 24(1):4-10. PubMed ID: 30656992
[TBL] [Abstract][Full Text] [Related]
13. New knowledge in the physiology of hormonal contraceptives.
Lobo RA; Stanczyk FZ
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
[TBL] [Abstract][Full Text] [Related]
14. How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations.
Mozzanega B; Cosmi E
Gynecol Endocrinol; 2011 Jun; 27(6):439-42. PubMed ID: 20670097
[TBL] [Abstract][Full Text] [Related]
15. Emergency contraception.
Gemzell-Danielsson K; Rabe T; Cheng L
Gynecol Endocrinol; 2013 Mar; 29 Suppl 1():1-14. PubMed ID: 23437846
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic and pharmacodynamic studies on vaginally administered levonorgestrel].
He CH
Shengzhi Yu Biyun; 1991 Nov; 11(4):12-8. PubMed ID: 12284919
[TBL] [Abstract][Full Text] [Related]
17. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
19. Ovarian function after seven years' use of a levonorgestrel IUD.
Barbosa I; Olsson SE; Odlind V; Goncalves T; Coutinho E
Adv Contracept; 1995 Jun; 11(2):85-95. PubMed ID: 7491859
[TBL] [Abstract][Full Text] [Related]
20. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
